Stromal Tumor Infiltrating Lymphocytes (sTILs) Were Associated with a Higher Grade and a Lower Stage of Indonesian Triple Negative Breast Cancers

Asian Pac J Cancer Prev. 2022 Aug 1;23(8):2749-2754. doi: 10.31557/APJCP.2022.23.8.2749.

Abstract

Objective: This study aimed to investigate the association of sTILs with clinicopathological parameters and overall survival (OS) in patients with triple negative breast cancer (TNBC).

Methods: One hundred and twenty-five paraffin embedded tissue of patients with TNBC, collected from Dr. Sardjito General Hospital Yogyakarta, Indonesia, between 2008-2017, were used in this study. Stromal TILs were examined from hematoxylin and eosin (H&E)-stained samples, and classified as either low or high score using 20% cut-off. Analysis of the association of sTILs with clinicopathological parameters, relative risk (RR) and OS used 95% confidence interval (CI) with significance set as p<0.05.

Results: The higher proportion of TNBC patients in this study were ≥40 years old (83.3%), high tumor grade (68%), tumor stage >IIIa (56%), alive (50.4%), and with low sTILs (54.4%). The results showed significant association between sTILs and a higher grade or a lower stage of tumor (B = 0.259, 95%CI = 0.090-0.468, p = 0.004 and B = -0.255, 95%CI = -0.433 - -0.080, p = 0.005, respectively ). Meanwhile sTILs were not associated with age at diagnosis (B = 0.027, 95%CI = -0.193 - 0.264 p = 0.758 nor 3-year OS of patients (HR = 0.342, 95%CI = 0.41 - 1.43 p = 0.402).

Conclusion: The results indicate that sTILs may serve as an additional pathological parameter for TNBC.

Keywords: TIL; TNBC; neoplasm grading; neoplasm staging; survival.

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis
  • Humans
  • Indonesia / epidemiology
  • Intracellular Signaling Peptides and Proteins
  • Lymphocytes, Tumor-Infiltrating* / pathology
  • Prognosis
  • Triple Negative Breast Neoplasms* / pathology

Substances

  • Biomarkers, Tumor
  • Intracellular Signaling Peptides and Proteins
  • STIL protein, human